DD A Audit for me doesn't have anything to do with the

New Post Public Reply Private Reply Replies (0) Message Board
toodles DirtyDawg #28520
364
DD A Audit for me doesn't have anything to do with the bashing on IHUB, its needed in my opinion to make the Company stronger and restore the CEO's respect/trust. The Audit will prove to the investors that this Company is real/Revenue is real, there's a whole different group of investors with deep pockets that want touch ONCI because of NO Audit.

Sifthouse is a long way off if it happens, I don't even count it in the picture, if a License is Obtained then we will get new investors, the 100k that was spent on it...I'm hushing no use....

Everyone looks at things different I look at from the very core of the business, this company has the potential to be huge if managed correct,

Wow we ran to.0192 on hype and the trust in Steve but didn't take it long to come crashing back down though.

The Company needs substantial Legitimacy to hold the PPS when we do get the correct news for a run up, right now we can't even get a small run.

The Longs invested here for a lot of them its 1-2-3- years but all they have seen is there money shrinking month after month,

What Steve is doing isn't easy by no means, Its HARD to sell some one something when they don't want to buy it now. Any new business has ups an downs that's a given stuff happens all the time, being just plain lazy, incompetent Lawyers. a whole host of things has held us back from just the 2 things I just mentioned.

I respect everyone's opinion on this board an wouldn't say anything to hurt any of them, I honestly care for everyone whos invested here and want all to make money.

Lets watch an see what happens when the PL Deal name is released, we'll see what kind of run happens and if it holds, I think a lot of the longs here are just waiting for any run to get them to break even or a little profit and ONCI will be history for them.

On4 Communications (ONCI) Stock Research Links

ONCI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors Urged to Act as Lawsuit Against Everus Builds

Updated Category News Views 97

Investigation of Claims Against Everus Construction Group Faruqi & Faruqi, LLP, a well-respected national securities law firm, has initiated an investigation into potential claims associated with Everus Construction Group, Inc. (NYSE: ECG). The firm specializes in shareholder rights and is aiming to provide support to affected investors after concerning revelations about...

Continue Reading
Heilongjiang Forum 2025: Elevating Macao's Global Tourism Standing

Updated Category News Views 107

Global Tourism Economy Forum 2025: A Landmark Event The Global Tourism Economy Forum (GTEF) made its notable debut outside of Macao by hosting the 2025 edition in Heilongjiang province, China. This forum gathered influential figures from the tourism sector and various related industries, fostering discussions aimed at exploring new avenues for cooperation and growth....

Continue Reading
Nextracker and T1 Energy Collaboration Drives Solar Growth

Updated Category News Views 198

Nextracker and T1 Energy Join Forces to Strengthen Solar Production Nextracker Inc. (NASDAQ: NXT) has recently established a partnership with T1 Energy Inc. (NYSE: TE) aimed at revolutionizing solar manufacturing. This collaboration will see the integration of Nextracker's cutting-edge steel module frame technology into T1 Energy's upcoming solar manufacturing plant,...

Continue Reading
Nathan Ballentine Steps In as Regional VP at New American Funding

Updated Category News Views 175

New Leadership at New American Funding New American Funding (NAF), a prominent independent mortgage lender, has announced a significant appointment. Nathan Ballentine is joining the team as the Regional Vice President, where he will play a pivotal role in propelling growth and development within the state. His expertise will be crucial as the company seeks to deepen its...

Continue Reading
CSL Behring Secures Approval for ANDEMBRY® in Japan

Updated Category News Views 341

CSL Behring's Recent Approval for ANDEMBRY® CSL Behring has announced a significant medical milestone with the approval of ANDEMBRY® (garadacimab) subcutaneous (S.C.) injection 200mg pens in Japan. This groundbreaking therapy is a first-in-class monoclonal antibody specifically designed to inhibit activated Factor XII (FXIIa), a crucial initiator in the hereditary...

Continue Reading